Skip to main content
. 2019 Jun 5;2019(6):CD009670. doi: 10.1002/14651858.CD009670.pub4

NCT01162239.

Trial name or title Maintaining nonsmoking
Methods Setting: USA
Participants 271
Interventions Pharmacotherapy: varenicline: 12 weeks, 1 mg bid
1. Participants have monthly meetings with medical staff
2. Participants receive monthly counselling with content based on a health education model
3. Participants receive monthly counselling with content based on a relapse prevention model plus access to ongoing medication treatment with varenicline
4. Participants receive monthly counselling with content based on a relapse prevention model
Outcomes Abstinence at 12, 24, 52, 64, 104 months
Starting date May 2010
Contact information University of California. No PI listed
Notes